Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/927066/000092706622000002/dva-20220209.htm
April 2024
February 2024
November 2023
August 2023
July 2023
July 2023
June 2023
May 2023
April 2023
March 2023
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/927066/000092706622000002/dva-20220209.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Davita Inc..
Davita Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Davita Inc. provided additional information to their SEC Filing as exhibits
Ticker: DVAEvents:
CIK: 927066
Form Type: 8-K Corporate News
Accession Number: 0000927066-22-000002
Submitted to the SEC: Wed Feb 09 2022 5:03:52 PM EST
Accepted by the SEC: Wed Feb 09 2022
Period: Wednesday, February 9, 2022
Industry: Health And Allied